Movicol Junior Neutral

Macrogol 3350, Sodium hydrogen carbonate, Potassium chloride and Sodium chloride, the active ingredients in Movicol Junior Neutral, are osmotic laxatives presented as an oral solution for oral use. It relieves constipation in pediatric patients. GNH USA supplies Movicol Junior Neutral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Junior Neutral is an osmotic laxative used to manage constipation in children. - Functional constipation in children: softens stool and facilitates regular bowel movements. - Chronic constipation in pediatric patients: improves stool frequency and reduces abdominal discomfort. - Encopresis secondary to constipation: helps clear retained stool and restore a normal bowel pattern.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of queasiness. - Mild abdominal pain: transient discomfort. - Diarrhoea: loose stools if excess fluid is retained. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Severe abdominal pain: persistent or worsening pain. - Blood in stool: indication of gastrointestinal irritation or injury.

Before using Movicol Junior Neutral, consider the following precautions: - Assess hydration status: ensure adequate fluid intake before and during treatment. - Monitor electrolytes: especially sodium and potassium during prolonged use. - Use with caution in renal impairment: adjust therapy if kidney function is reduced. - Avoid in patients with known hypersensitivity to any component. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Movicol Junior Neutral may interact with other medicines as follows: Major Interactions (Avoid): - Concomitant high‑dose potassium supplements: risk of hyperkalaemia. - Loop diuretics: may exacerbate electrolyte loss. - Lithium therapy: increased lithium levels due to altered renal clearance. Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminium: may reduce laxative efficacy. - Oral antibiotics: possible reduced absorption of the antibiotic. - Other osmotic laxatives: additive effect leading to dehydration.